Header Logo

Connection

Jennifer McClure to Smoking Cessation

This is a "connection" page, showing publications Jennifer McClure has written about Smoking Cessation.
Connection Strength

11.677
  1. Feasibility, Acceptability, and Potential Impact of a Novel mHealth App for Smokers Ambivalent About Quitting: Randomized Pilot Study. JMIR Mhealth Uhealth. 2023 06 28; 11:e46155.
    View in: PubMed
    Score: 0.770
  2. Design and methods of a randomized trial testing the novel Wellness Intervention for Smokers Living with HIV (WISH). Contemp Clin Trials. 2021 11; 110:106486.
    View in: PubMed
    Score: 0.686
  3. Exploring the "active ingredients" of an online smoking intervention: a randomized factorial trial. Nicotine Tob Res. 2014 Aug; 16(8):1129-39.
    View in: PubMed
    Score: 0.406
  4. Leveraging the US tobacco quitline infrastructure to promote oral health: feedback from key stakeholders. Prev Med. 2014 Mar; 60:134-5.
    View in: PubMed
    Score: 0.399
  5. Using multiple imputations to accommodate time-outs in online interventions. J Med Internet Res. 2013 Nov 21; 15(11):e252.
    View in: PubMed
    Score: 0.396
  6. [More] evidence to support oral health promotion services targeted to smokers calling tobacco quitlines in the United States. BMC Public Health. 2013 Apr 11; 13:336.
    View in: PubMed
    Score: 0.379
  7. The effect of program design on engagement with an internet-based smoking intervention: randomized factorial trial. J Med Internet Res. 2013 Mar 25; 15(3):e69.
    View in: PubMed
    Score: 0.378
  8. Pharmacogenetic smoking cessation intervention in a health care setting: a pilot feasibility study. Nicotine Tob Res. 2013 Feb; 15(2):518-26.
    View in: PubMed
    Score: 0.364
  9. Questions about quitting (Q2): design and methods of a Multiphase Optimization Strategy (MOST) randomized screening experiment for an online, motivational smoking cessation intervention. Contemp Clin Trials. 2012 Sep; 33(5):1094-102.
    View in: PubMed
    Score: 0.360
  10. Feasibility and acceptability of a multiple risk factor intervention: the Step Up randomized pilot trial. BMC Public Health. 2011 Mar 17; 11:167.
    View in: PubMed
    Score: 0.329
  11. Impact of spirometry feedback and brief motivational counseling on long-term smoking outcomes: a comparison of smokers with and without lung impairment. Patient Educ Couns. 2010 Aug; 80(2):280-3.
    View in: PubMed
    Score: 0.315
  12. Smoking outcome by psychiatric history after behavioral and varenicline treatment. J Subst Abuse Treat. 2010 Jun; 38(4):394-402.
    View in: PubMed
    Score: 0.308
  13. Impact of a brief motivational smoking cessation intervention the Get PHIT randomized controlled trial. Am J Prev Med. 2009 Aug; 37(2):116-23.
    View in: PubMed
    Score: 0.291
  14. Immediate and short-term impact of a brief motivational smoking intervention using a biomedical risk assessment: the Get PHIT trial. Nicotine Tob Res. 2009 Apr; 11(4):394-403.
    View in: PubMed
    Score: 0.286
  15. Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline. J Gen Intern Med. 2009 May; 24(5):563-9.
    View in: PubMed
    Score: 0.285
  16. Canary in a coal mine? Interest in bupropion SR use among smokers in the COMPASS trial. Nicotine Tob Res. 2008 Dec; 10(12):1815-6.
    View in: PubMed
    Score: 0.280
  17. Nicotine patches and uninsured quitline callers. A randomized trial of two versus eight weeks. Am J Prev Med. 2008 Aug; 35(2):103-10.
    View in: PubMed
    Score: 0.274
  18. Predictors of 12-month outcome in smokers who received bupropion sustained-release for smoking cessation. CNS Drugs. 2008; 22(3):239-56.
    View in: PubMed
    Score: 0.263
  19. Interest in an online smoking cessation program and effective recruitment strategies: results from Project Quit. J Med Internet Res. 2006 Aug 22; 8(3):e14.
    View in: PubMed
    Score: 0.239
  20. Tailoring nicotine replacement therapy: rationale and potential approaches. CNS Drugs. 2006; 20(4):281-91.
    View in: PubMed
    Score: 0.229
  21. Proactive, motivationally enhanced smoking cessation counseling among women with elevated cervical cancer risk. Nicotine Tob Res. 2005 Dec; 7(6):881-9.
    View in: PubMed
    Score: 0.228
  22. Motivating prepartum smoking cessation: a consideration of biomarker feedback. Nicotine Tob Res. 2004 Apr; 6 Suppl 2:S153-61.
    View in: PubMed
    Score: 0.203
  23. Self-administered treatment for smoking cessation. J Clin Psychol. 2003 Mar; 59(3):305-19.
    View in: PubMed
    Score: 0.188
  24. The relation between alcohol consumption and smoking abstinence: results from the Working Well Trial. Addict Behav. 2002 May-Jun; 27(3):367-79.
    View in: PubMed
    Score: 0.178
  25. Capturing tobacco status using an automated billing system: steps toward a tobacco registry. Nicotine Tob Res. 2002; 4 Suppl 1:S31-7.
    View in: PubMed
    Score: 0.174
  26. Are biomarkers a useful aid in smoking cessation? A review and analysis of the literature. Behav Med. 2001; 27(1):37-47.
    View in: PubMed
    Score: 0.162
  27. Which Method of Assessing Depression and Anxiety Best Predicts Smoking Cessation: Screening Instruments or Self-Reported Conditions? Nicotine Tob Res. 2020 10 08; 22(10):1860-1866.
    View in: PubMed
    Score: 0.159
  28. Long-Term Smoking Cessation Outcomes for Sexual Minority Versus Nonminority Smokers in a Large Randomized Controlled Trial of Two Web-Based Interventions. Nicotine Tob Res. 2020 08 24; 22(9):1596-1604.
    View in: PubMed
    Score: 0.158
  29. Comparing Treatment Acceptability and 12-Month Cessation Rates in Response to Web-Based Smoking Interventions Among Smokers Who Do and Do Not Screen Positive for Affective Disorders: Secondary Analysis. J Med Internet Res. 2019 06 19; 21(6):e13500.
    View in: PubMed
    Score: 0.146
  30. Smokers with bipolar disorder, other affective disorders, and no mental health conditions: Comparison of baseline characteristics and success at quitting in a large 12-month behavioral intervention randomized trial. Drug Alcohol Depend. 2018 12 01; 193:35-41.
    View in: PubMed
    Score: 0.139
  31. Abstinence rates achieved with buproprion corrected. Oncology (Williston Park). 1998 Sep; 12(9):1303.
    View in: PubMed
    Score: 0.138
  32. Smoking cessation: recent developments in behavioral and pharmacologic interventions. Oncology (Williston Park). 1998 Feb; 12(2):249-56, 259; discussion 260, 265, 2.
    View in: PubMed
    Score: 0.132
  33. Positive Affect as a Predictor of Smoking Cessation and Relapse: Does It Offer Unique Predictive Value among Depressive Symptom Domains? Subst Use Misuse. 2018 05 12; 53(6):980-988.
    View in: PubMed
    Score: 0.131
  34. Scheduled reduced smoking: effects on smoking abstinence and potential mechanisms of action. Addict Behav. 1997 Nov-Dec; 22(6):759-67.
    View in: PubMed
    Score: 0.130
  35. Oral health 4 life: Design and methods of a semi-pragmatic randomized trial to promote oral health care and smoking abstinence among tobacco quitline callers. Contemp Clin Trials. 2017 06; 57:90-97.
    View in: PubMed
    Score: 0.125
  36. Differential prevalence of established risk factors for poor cessation outcomes among smokers by level of social anxiety. Am J Addict. 2017 Mar; 26(2):176-182.
    View in: PubMed
    Score: 0.124
  37. Smoking cessation. 3: Needed healthcare policy changes. Behav Med. 1997; 23(1):29-34.
    View in: PubMed
    Score: 0.123
  38. Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption. PLoS One. 2015; 10(7):e0126113.
    View in: PubMed
    Score: 0.111
  39. Acceptance and Commitment Therapy and nicotine patch for smokers with bipolar disorder: preliminary evaluation of in-person and telephone-delivered treatment. Bipolar Disord. 2015 Aug; 17(5):560-6.
    View in: PubMed
    Score: 0.109
  40. Organic cation transporter variation and response to smoking cessation therapies. Nicotine Tob Res. 2014 Dec; 16(12):1638-46.
    View in: PubMed
    Score: 0.104
  41. Positive smoking outcome expectancies mediate the association between negative affect and smoking urge among women during a quit attempt. Exp Clin Psychopharmacol. 2014 Aug; 22(4):332-40.
    View in: PubMed
    Score: 0.102
  42. Positive smoking outcome expectancies mediate the relation between alcohol consumption and smoking urge among women during a quit attempt. Psychol Addict Behav. 2014 Mar; 28(1):163-72.
    View in: PubMed
    Score: 0.101
  43. Individual and combined effects of multiple high-risk triggers on postcessation smoking urge and lapse. Nicotine Tob Res. 2014 May; 16(5):569-75.
    View in: PubMed
    Score: 0.099
  44. Alcohol consumption and urges to smoke among women during a smoking cessation attempt. Exp Clin Psychopharmacol. 2013 Feb; 21(1):29-37.
    View in: PubMed
    Score: 0.094
  45. Early cessation success or failure among women attempting to quit smoking: trajectories and volatility of urge and negative mood during the first postcessation week. J Abnorm Psychol. 2011 Aug; 120(3):596-606.
    View in: PubMed
    Score: 0.084
  46. A randomized clinical trial of a palmtop computer-delivered treatment for smoking relapse prevention among women. Psychol Addict Behav. 2011 Jun; 25(2):365-71.
    View in: PubMed
    Score: 0.083
  47. The efficacy of computer-delivered treatment for smoking cessation. Cancer Epidemiol Biomarkers Prev. 2011 Jul; 20(7):1555-7.
    View in: PubMed
    Score: 0.083
  48. Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine Tob Res. 2011 May; 13(5):361-8.
    View in: PubMed
    Score: 0.082
  49. Utilization of services in a randomized trial testing phone- and web-based interventions for smoking cessation. Nicotine Tob Res. 2011 May; 13(5):319-27.
    View in: PubMed
    Score: 0.081
  50. Behavioral counseling and varenicline treatment for smoking cessation. Am J Prev Med. 2010 May; 38(5):482-90.
    View in: PubMed
    Score: 0.077
  51. Using free patches to improve reach of the Oregon Quit Line. J Public Health Manag Pract. 2009 Sep-Oct; 15(5):401-8.
    View in: PubMed
    Score: 0.074
  52. Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting. J Subst Abuse Treat. 2009 Jun; 36(4):428-34.
    View in: PubMed
    Score: 0.070
  53. The role of engagement in a tailored web-based smoking cessation program: randomized controlled trial. J Med Internet Res. 2008 Nov 04; 10(5):e36.
    View in: PubMed
    Score: 0.070
  54. The impact of a free nicotine patch starter kit on quit rates in a state quit line. Nicotine Tob Res. 2008 Sep; 10(9):1511-6.
    View in: PubMed
    Score: 0.069
  55. Web-based smoking-cessation programs: results of a randomized trial. Am J Prev Med. 2008 May; 34(5):373-81.
    View in: PubMed
    Score: 0.067
  56. Cigarette smoking and nicotine dependence. Med Clin North Am. 2004 Nov; 88(6):1453-65, x.
    View in: PubMed
    Score: 0.053
  57. The United States National Cancer Institute's Coordinated Research Effort on Tobacco Use as a Major Cause of Morbidity and Mortality among People with HIV. Nicotine Tob Res. 2021 01 22; 23(2):407-410.
    View in: PubMed
    Score: 0.041
  58. An evaluation of videotaped vignettes for smoking cessation and relapse prevention during pregnancy: the very important pregnant smokers (VIPS) program. Tob Control. 2000; 9 Suppl 3:III61-3.
    View in: PubMed
    Score: 0.038
  59. Smoking cessation. 1: An overview of research. Behav Med. 1997; 23(1):5-13.
    View in: PubMed
    Score: 0.031
  60. Smoking cessation. 2: Components of effective intervention. Behav Med. 1997; 23(1):15-27.
    View in: PubMed
    Score: 0.031
  61. Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes. Pharmacogenomics J. 2012 Aug; 12(4):349-58.
    View in: PubMed
    Score: 0.021
  62. Clinical trial participant characteristics and saliva and DNA metrics. BMC Med Res Methodol. 2009 Oct 29; 9:71.
    View in: PubMed
    Score: 0.019
  63. Concomitant use of cigarettes and smokeless tobacco: prevalence, correlates, and predictors of tobacco cessation. Prev Med. 2002 Jun; 34(6):638-48.
    View in: PubMed
    Score: 0.011

© 2025 Kaiser Permanente